Insulet
PODD
153 hedge funds and large institutions have $1.88B invested in Insulet in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 66 reducing their positions, and 40 closing their positions.
36% more call options, than puts
Call options by funds: $2.76M | Put options by funds: $2.02M
9% less capital invested
Capital invested by funds: $2.05B → $1.88B (-$175M)
12% less funds holding
Funds holding: 173 → 153 (-20)
24% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 66
48% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 40
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$64.9M |
| 2 |
BM
Bridger Management
New York
|
+$53.2M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$38.1M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$17.7M |
| 5 |
VAM
Visium Asset Management
New York
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$63.5M |
| 2 |
O
OrbiMed
New York
|
-$45.5M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$32.9M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$18.7M |
| 5 |
TA
Teachers Advisors
New York
|
-$17.9M |
PODD Hedge Fund Activity: Q2 2015 in Review
153 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2015, worth a combined $1.88B — down 8.5% from $2.05B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of PODD and 21 opened new positions — a net loss of 19 holders — while 66 trimmed existing stakes and 50 added.
The largest buyer was Primecap Management, adding an estimated $64.9M. The largest seller was Fidelity Investments, cutting an estimated $63.5M.
- 153 institutional investors held Insulet (PODD) as of Q2 2015, down from 173 in Q1 2015.
- Funds reported $1.88B of Insulet stock for Q2 2015, down 8.5% quarter-over-quarter.
- 21 funds opened new Insulet positions in Q2 2015 and 40 closed out, a net change of -19 holders.
- The largest Insulet buyer in Q2 2015 was Primecap Management, an estimated $64.9M added.
- The largest Insulet seller in Q2 2015 was Fidelity Investments, an estimated $63.5M sold.
Based on aggregated 13F filings for Q2 2015.